Phaos Technology Holdings (Cayman) (POAS) Equity Ratio (2024 - 2025)
Phaos Technology Holdings (Cayman) posted quarterly Equity Ratio of 1.01 for Q2 2025, down 280.18% year-on-year from 0.56 in Q2 2024, and down 280.18% on a QoQ basis from 0.56 in Q2 2024.
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Equity Ratio data on file, last reported at 1.01 in Q2 2025.
- For the quarter ending Q2 2025, Equity Ratio fell 280.18% year-over-year to 1.01; the trailing twelve-month figure through Apr 2025 stood at 1.01 (down 280.18% YoY), and the FY2025 full-year result was 1.01, down 280.18% from the prior year.
- Equity Ratio for Q2 2025 stood at 1.01, down from 0.56 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.56 in Q2 2024 and bottomed at 1.01 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Phaos Technology Holdings (Cayman) | 6.83 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | -1.01 |
| Apr 30, 2024 | 0.56 |